FDA Approvals Provide Advances for a Range of Cancer Types
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
Tag: blood cancers
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
Acute lymphoblastic leukemia (ALL) is an aggressive cancer of the bone marrow and the blood that develops in either...
Lymphomas are a collection of blood cancers stemming from aberrant lymphocytes, which are critical components of the immune system....
Multiple myeloma arises in immune cells called plasma cells. It is one of the most commonly diagnosed hematological malignancies...
Myeloma is the third most common blood cancer in the United States, arising in the plasma cells of the...
In a study published in the AACR’s journal Cancer Discovery in December, a team of researchers from the Perelman...
Rarely do investigators in two distinct fields of cancer research have the time to come together for an evening...